Global pharma powerhoutilize Eli Lilly and Incyte have announced a major regulatory milestone today: the European Medicines Agency’s (EMA) Committee…
Read More
Eli Lilly stock slides, Pinterest sells off, Expedia and Block gain after hours
Crocs (CROX) forecast a 9% to 11% decline in third quarter revenue on Thursday, as tariffs and a softer consumer…
Read More
Eli Lilly lands “bargain” deal to acquire Verve Therapeutics for $1.3bn
Eli Lilly has agreed to acquire cardiovascular disease treatment specialist Verve Therapeutics in a deal potentially rising to $1.3bn, with…
Read More
